 | • レポートコード：MRC2-11QY05655 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はエリキュースのグローバル市場について調査・分析したレポートです。種類別（2.5 mg、5 mg）市場規模、用途別（深部静脈血栓症（DVT）、肺塞栓症（PE））市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別エリキュースの競争状況、市場シェア ・世界のエリキュース市場：種類別市場規模 2015年-2020年（2.5 mg、5 mg） ・世界のエリキュース市場：種類別市場規模予測 2021年-2026年（2.5 mg、5 mg） ・世界のエリキュース市場：用途別市場規模 2015年-2020年（深部静脈血栓症（DVT）、肺塞栓症（PE）） ・世界のエリキュース市場：用途別市場規模予測 2021年-2026年（深部静脈血栓症（DVT）、肺塞栓症（PE）） ・北米のエリキュース市場分析：米国、カナダ ・ヨーロッパのエリキュース市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのエリキュース市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のエリキュース市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのエリキュース市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Eliquis Market
The global Eliquis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Eliquis Scope and Market Size
Eliquis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Eliquis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Eliquis market is segmented into
2.5 mg
5 mg
Segment by Application, the Eliquis market is segmented into
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Regional and Country-level Analysis
The Eliquis market is analysed and market size information is provided by regions (countries).
The key regions covered in the Eliquis market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Eliquis Market Share Analysis
Eliquis market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Eliquis business, the date to enter into the Eliquis market, Eliquis product introduction, recent developments, etc.
The major vendors covered:
Pfizer
…
1 Study Coverage
1.1 Eliquis Product Introduction
1.2 Market Segments
1.3 Key Eliquis Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Eliquis Market Size Growth Rate by Type
1.4.2 2.5 mg
1.4.3 5 mg
1.5 Market by Application
1.5.1 Global Eliquis Market Size Growth Rate by Application
1.5.2 Deep Vein Thrombosis (DVT)
1.5.3 Pulmonary Embolism (PE)
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Eliquis Market Size, Estimates and Forecasts
2.1.1 Global Eliquis Revenue 2015-2026
2.1.2 Global Eliquis Sales 2015-2026
2.2 Global Eliquis, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Eliquis Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Eliquis Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Eliquis Competitor Landscape by Players
3.1 Eliquis Sales by Manufacturers
3.1.1 Eliquis Sales by Manufacturers (2015-2020)
3.1.2 Eliquis Sales Market Share by Manufacturers (2015-2020)
3.2 Eliquis Revenue by Manufacturers
3.2.1 Eliquis Revenue by Manufacturers (2015-2020)
3.2.2 Eliquis Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Eliquis Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Eliquis Revenue in 2019
3.2.5 Global Eliquis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Eliquis Price by Manufacturers
3.4 Eliquis Manufacturing Base Distribution, Product Types
3.4.1 Eliquis Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Eliquis Product Type
3.4.3 Date of International Manufacturers Enter into Eliquis Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Eliquis Market Size by Type (2015-2020)
4.1.1 Global Eliquis Sales by Type (2015-2020)
4.1.2 Global Eliquis Revenue by Type (2015-2020)
4.1.3 Eliquis Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Eliquis Market Size Forecast by Type (2021-2026)
4.2.1 Global Eliquis Sales Forecast by Type (2021-2026)
4.2.2 Global Eliquis Revenue Forecast by Type (2021-2026)
4.2.3 Eliquis Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Eliquis Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Eliquis Market Size by Application (2015-2020)
5.1.1 Global Eliquis Sales by Application (2015-2020)
5.1.2 Global Eliquis Revenue by Application (2015-2020)
5.1.3 Eliquis Price by Application (2015-2020)
5.2 Eliquis Market Size Forecast by Application (2021-2026)
5.2.1 Global Eliquis Sales Forecast by Application (2021-2026)
5.2.2 Global Eliquis Revenue Forecast by Application (2021-2026)
5.2.3 Global Eliquis Price Forecast by Application (2021-2026)
6 North America
6.1 North America Eliquis by Country
6.1.1 North America Eliquis Sales by Country
6.1.2 North America Eliquis Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Eliquis Market Facts & Figures by Type
6.3 North America Eliquis Market Facts & Figures by Application
7 Europe
7.1 Europe Eliquis by Country
7.1.1 Europe Eliquis Sales by Country
7.1.2 Europe Eliquis Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Eliquis Market Facts & Figures by Type
7.3 Europe Eliquis Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Eliquis by Region
8.1.1 Asia Pacific Eliquis Sales by Region
8.1.2 Asia Pacific Eliquis Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Eliquis Market Facts & Figures by Type
8.3 Asia Pacific Eliquis Market Facts & Figures by Application
9 Latin America
9.1 Latin America Eliquis by Country
9.1.1 Latin America Eliquis Sales by Country
9.1.2 Latin America Eliquis Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Eliquis Market Facts & Figures by Type
9.3 Central & South America Eliquis Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Eliquis by Country
10.1.1 Middle East and Africa Eliquis Sales by Country
10.1.2 Middle East and Africa Eliquis Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Eliquis Market Facts & Figures by Type
10.3 Middle East and Africa Eliquis Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Eliquis Products Offered
11.1.5 Pfizer Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Eliquis Products Offered
11.1.5 Pfizer Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Eliquis Market Estimates and Projections by Region
12.1.1 Global Eliquis Sales Forecast by Regions 2021-2026
12.1.2 Global Eliquis Revenue Forecast by Regions 2021-2026
12.2 North America Eliquis Market Size Forecast (2021-2026)
12.2.1 North America: Eliquis Sales Forecast (2021-2026)
12.2.2 North America: Eliquis Revenue Forecast (2021-2026)
12.2.3 North America: Eliquis Market Size Forecast by Country (2021-2026)
12.3 Europe Eliquis Market Size Forecast (2021-2026)
12.3.1 Europe: Eliquis Sales Forecast (2021-2026)
12.3.2 Europe: Eliquis Revenue Forecast (2021-2026)
12.3.3 Europe: Eliquis Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Eliquis Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Eliquis Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Eliquis Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Eliquis Market Size Forecast by Region (2021-2026)
12.5 Latin America Eliquis Market Size Forecast (2021-2026)
12.5.1 Latin America: Eliquis Sales Forecast (2021-2026)
12.5.2 Latin America: Eliquis Revenue Forecast (2021-2026)
12.5.3 Latin America: Eliquis Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Eliquis Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Eliquis Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Eliquis Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Eliquis Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Eliquis Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Eliquis Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Eliquis Market Segments
Table 2. Ranking of Global Top Eliquis Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Eliquis Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of 2.5 mg
Table 5. Major Manufacturers of 5 mg
Table 6. Global Eliquis Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Eliquis Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Eliquis Sales by Regions 2015-2020 (K MT)
Table 9. Global Eliquis Sales Market Share by Regions (2015-2020)
Table 10. Global Eliquis Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Eliquis Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Eliquis Sales Share by Manufacturers (2015-2020)
Table 13. Global Eliquis Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Eliquis by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eliquis as of 2019)
Table 15. Eliquis Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Eliquis Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Eliquis Price (2015-2020) (USD/MT)
Table 18. Eliquis Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Eliquis Product Type
Table 20. Date of International Manufacturers Enter into Eliquis Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Eliquis Sales by Type (2015-2020) (K MT)
Table 23. Global Eliquis Sales Share by Type (2015-2020)
Table 24. Global Eliquis Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Eliquis Revenue Share by Type (2015-2020)
Table 26. Eliquis Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Eliquis Sales by Application (2015-2020) (K MT)
Table 28. Global Eliquis Sales Share by Application (2015-2020)
Table 29. North America Eliquis Sales by Country (2015-2020) (K MT)
Table 30. North America Eliquis Sales Market Share by Country (2015-2020)
Table 31. North America Eliquis Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Eliquis Revenue Market Share by Country (2015-2020)
Table 33. North America Eliquis Sales by Type (2015-2020) (K MT)
Table 34. North America Eliquis Sales Market Share by Type (2015-2020)
Table 35. North America Eliquis Sales by Application (2015-2020) (K MT)
Table 36. North America Eliquis Sales Market Share by Application (2015-2020)
Table 37. Europe Eliquis Sales by Country (2015-2020) (K MT)
Table 38. Europe Eliquis Sales Market Share by Country (2015-2020)
Table 39. Europe Eliquis Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Eliquis Revenue Market Share by Country (2015-2020)
Table 41. Europe Eliquis Sales by Type (2015-2020) (K MT)
Table 42. Europe Eliquis Sales Market Share by Type (2015-2020)
Table 43. Europe Eliquis Sales by Application (2015-2020) (K MT)
Table 44. Europe Eliquis Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Eliquis Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Eliquis Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Eliquis Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Eliquis Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Eliquis Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Eliquis Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Eliquis Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Eliquis Sales Market Share by Application (2015-2020)
Table 53. Latin America Eliquis Sales by Country (2015-2020) (K MT)
Table 54. Latin America Eliquis Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Eliquis Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Eliquis Revenue Market Share by Country (2015-2020)
Table 57. Latin America Eliquis Sales by Type (2015-2020) (K MT)
Table 58. Latin America Eliquis Sales Market Share by Type (2015-2020)
Table 59. Latin America Eliquis Sales by Application (2015-2020) (K MT)
Table 60. Latin America Eliquis Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Eliquis Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Eliquis Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Eliquis Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Eliquis Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Eliquis Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Eliquis Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Eliquis Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Eliquis Sales Market Share by Application (2015-2020)
Table 69. Pfizer Corporation Information
Table 70. Pfizer Description and Major Businesses
Table 71. Pfizer Eliquis Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Pfizer Product
Table 73. Pfizer Recent Development
Table 74. Global Eliquis Sales Forecast by Regions (2021-2026) (K MT)
Table 75. Global Eliquis Sales Market Share Forecast by Regions (2021-2026)
Table 76. Global Eliquis Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 77. Global Eliquis Revenue Market Share Forecast by Regions (2021-2026)
Table 78. North America: Eliquis Sales Forecast by Country (2021-2026) (K MT)
Table 79. North America: Eliquis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 80. Europe: Eliquis Sales Forecast by Country (2021-2026) (K MT)
Table 81. Europe: Eliquis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 82. Asia Pacific: Eliquis Sales Forecast by Region (2021-2026) (K MT)
Table 83. Asia Pacific: Eliquis Revenue Forecast by Region (2021-2026) (US$ Million)
Table 84. Latin America: Eliquis Sales Forecast by Country (2021-2026) (K MT)
Table 85. Latin America: Eliquis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 86. Middle East and Africa: Eliquis Sales Forecast by Country (2021-2026) (K MT)
Table 87. Middle East and Africa: Eliquis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 88. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 89. Key Challenges
Table 90. Market Risks
Table 91. Main Points Interviewed from Key Eliquis Players
Table 92. Eliquis Customers List
Table 93. Eliquis Distributors List
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Eliquis Product Picture
Figure 2. Global Eliquis Sales Market Share by Type in 2020 & 2026
Figure 3. 2.5 mg Product Picture
Figure 4. 5 mg Product Picture
Figure 5. Global Eliquis Sales Market Share by Application in 2020 & 2026
Figure 6. Deep Vein Thrombosis (DVT)
Figure 7. Pulmonary Embolism (PE)
Figure 8. Eliquis Report Years Considered
Figure 9. Global Eliquis Market Size 2015-2026 (US$ Million)
Figure 10. Global Eliquis Sales 2015-2026 (K MT)
Figure 11. Global Eliquis Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Eliquis Sales Market Share by Region (2015-2020)
Figure 13. Global Eliquis Sales Market Share by Region in 2019
Figure 14. Global Eliquis Revenue Market Share by Region (2015-2020)
Figure 15. Global Eliquis Revenue Market Share by Region in 2019
Figure 16. Global Eliquis Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Eliquis Revenue in 2019
Figure 18. Eliquis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Eliquis Sales Market Share by Type (2015-2020)
Figure 20. Global Eliquis Sales Market Share by Type in 2019
Figure 21. Global Eliquis Revenue Market Share by Type (2015-2020)
Figure 22. Global Eliquis Revenue Market Share by Type in 2019
Figure 23. Global Eliquis Market Share by Price Range (2015-2020)
Figure 24. Global Eliquis Sales Market Share by Application (2015-2020)
Figure 25. Global Eliquis Sales Market Share by Application in 2019
Figure 26. Global Eliquis Revenue Market Share by Application (2015-2020)
Figure 27. Global Eliquis Revenue Market Share by Application in 2019
Figure 28. North America Eliquis Sales Growth Rate 2015-2020 (K MT)
Figure 29. North America Eliquis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Eliquis Sales Market Share by Country in 2019
Figure 31. North America Eliquis Revenue Market Share by Country in 2019
Figure 32. U.S. Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 33. U.S. Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 35. Canada Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Eliquis Market Share by Type in 2019
Figure 37. North America Eliquis Market Share by Application in 2019
Figure 38. Europe Eliquis Sales Growth Rate 2015-2020 (K MT)
Figure 39. Europe Eliquis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Eliquis Sales Market Share by Country in 2019
Figure 41. Europe Eliquis Revenue Market Share by Country in 2019
Figure 42. Germany Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 43. Germany Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 45. France Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 47. U.K. Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 49. Italy Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 51. Russia Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Eliquis Market Share by Type in 2019
Figure 53. Europe Eliquis Market Share by Application in 2019
Figure 54. Asia Pacific Eliquis Sales Growth Rate 2015-2020 (K MT)
Figure 55. Asia Pacific Eliquis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Eliquis Sales Market Share by Region in 2019
Figure 57. Asia Pacific Eliquis Revenue Market Share by Region in 2019
Figure 58. China Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 59. China Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 61. Japan Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 63. South Korea Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 65. India Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 67. Australia Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 69. Taiwan Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 71. Indonesia Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 73. Thailand Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 75. Malaysia Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 77. Philippines Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 79. Vietnam Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Eliquis Market Share by Type in 2019
Figure 81. Asia Pacific Eliquis Market Share by Application in 2019
Figure 82. Latin America Eliquis Sales Growth Rate 2015-2020 (K MT)
Figure 83. Latin America Eliquis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Eliquis Sales Market Share by Country in 2019
Figure 85. Latin America Eliquis Revenue Market Share by Country in 2019
Figure 86. Mexico Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 87. Mexico Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 89. Brazil Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 91. Argentina Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Eliquis Market Share by Type in 2019
Figure 93. Latin America Eliquis Market Share by Application in 2019
Figure 94. Middle East and Africa Eliquis Sales Growth Rate 2015-2020 (K MT)
Figure 95. Middle East and Africa Eliquis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Eliquis Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Eliquis Revenue Market Share by Country in 2019
Figure 98. Turkey Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 99. Turkey Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 101. Saudi Arabia Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Eliquis Sales Growth Rate (2015-2020) (K MT)
Figure 103. U.A.E Eliquis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Eliquis Market Share by Type in 2019
Figure 105. Middle East and Africa Eliquis Market Share by Application in 2019
Figure 106. North America Eliquis Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 107. North America Eliquis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Eliquis Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. Europe Eliquis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Eliquis Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Asia Pacific Eliquis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Eliquis Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Latin America Eliquis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Eliquis Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Middle East and Africa Eliquis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
深部静脈血栓症（DVT）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Deep Vein Thrombosis (DVT) Drug Market The global Deep Vein Thrombosis (DVT) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Deep Vein Thrombosis (DVT) Drug Scope and Market Si…- 網膜静脈閉塞症治療薬の世界市場（～2026年） Retinal vein occlusion (RVO) is a sight-threatening retinal vascular disorder associated with macular edema and neovascularization. The RVO is mainly of two types based on the anatomy of the vein occlusion. The two types are branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CR…
- 静脈瘤治療の世界市場（～2026年） Varicose Veins also referred to as varicosities are swollen, blue, twisted veins that appear on the skin. These are often seen near the legs. Market Analysis and Insights: Global Varicose Vein Treatment Market The global Varicose Vein Treatment market size is projected to reach US$ 401.9 million by …
- 静脈血栓塞栓症（VTE）治療薬の世界市場（～2026年） Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the circulatory system that leads to impeded blood flow, which can have serious consequences in the affected individual (Heit, 2015). In VTE, a DVT is a clot tha…
- 肺動脈性肺高血圧症（PAH）の世界市場（～2026年） Market Analysis and Insights: Global Pulmonary Arterial Hypertension (PAH) Market The global Pulmonary Arterial Hypertension (PAH) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Pulmonary Arterial Hypertension (PAH) S…